peripher
cell
polar
toward
type
type
cytokin
immun
respons
tcr
engag
cell
select
peptid
plu
selfmhc
thymu
requir
tcr
engag
hypothes
type
cytokin
may
polar
develop
cell
cultur
thymi
bbdr
rat
adult
thymu
organ
cultur
atoc
type
cytokin
condit
absenc
exogen
antigen
type
cytokinecondit
atoc
gener
cell
spontan
secret
high
level
ifn
second
exposur
type
cytokin
increas
ifn
secret
cell
blast
express
activ
marker
studi
use
block
antibodi
pharmacolog
inhibitor
suggest
cognat
tcrmhcligand
interact
import
activ
block
antimhc
class
plu
antimhc
class
ii
antibodi
neutral
antibodi
mapkinas
inhibitor
reduc
ifn
product
cyclosporin
prevent
tcr
signal
inhibit
ifn
product
data
demonstr
exposur
type
cytokin
intrathym
develop
polar
differenti
cell
suggest
mechan
intrathym
exposur
type
cytokin
may
modul
cell
develop
key
determin
respons
effector
cell
antigen
cytokin
environ
encount
cognat
engag
tcr
polar
cell
toward
type
cytokin
profil
character
high
ifn
low
secret
wherea
polar
cell
toward
type
cytokin
profil
character
high
low
ifn
secret
type
polar
cell
effect
control
intracellular
pathogen
implic
cellmedi
autoimmun
disord
type
polar
cell
effect
control
extracellular
pathogen
helminth
also
promot
humor
immun
includ
igemedi
allerg
respons
ex
vivo
exposur
cell
type
type
cytokin
environ
cognat
tcr
interact
mhc
plu
antigen
rapidli
polar
cytokin
secret
profil
known
cell
produc
need
gener
type
respons
vivo
nk
cell
basophil
mast
cell
cell
candid
sourc
promot
type
cytokin
respons
vivo
produc
primarili
dendrit
cell
macrophag
secret
rapidli
respons
infect
mani
intracellular
pathogen
microbi
lp
bacteri
dna
contain
cpg
motif
leishmania
antigen
also
potent
induc
phagocyt
cell
respons
innat
immun
system
infecti
agent
microbi
product
vigor
enough
increas
level
circul
exampl
infect
murin
cytomegaloviru
toxoplasma
gondii
exposur
lp
dsrna
viral
mimet
polyinosin
polycytidyl
acid
poli
c
markedli
increas
circul
level
vivo
mice
activ
apc
pathogen
caus
secret
could
therefor
system
effect
cell
also
produc
absenc
infect
dendrit
cell
cognat
interact
cell
thymu
role
polar
cytokin
environ
regul
peripher
cell
respons
studi
extens
known
cell
differenti
thymu
also
suscept
polar
posit
neg
select
selfpeptidemhc
complex
thymocyt
develop
requir
engag
tcr
hypothes
thymic
cell
polar
test
hypothesi
use
rat
adult
thymu
organ
cultur
atoc
examin
effect
exposur
type
cytokin
environ
cell
develop
chose
studi
thymi
bbdr
rat
shown
previous
bbdr
rat
atoc
recapitul
normal
thymocyt
develop
gener
normal
ratio
function
singl
posit
tcr
hi
cell
bbdr
rat
phenotyp
normal
diseasefre
induc
develop
autoimmun
diabet
environment
perturb
includ
viral
infect
diabet
anim
associ
type
immun
respons
report
exposur
bbdr
rat
atoc
type
cytokin
environ
gener
activ
cell
spontan
secret
high
level
ifn
use
block
antibodi
pharmacolog
inhibitor
document
tcrmhcligand
interact
endogen
import
activ
preselect
thymocyt
singl
posit
thymocyt
polar
increas
ifn
product
data
document
develop
rat
thymocyt
like
peripher
cell
suscept
polar
effect
type
cytokin
viral
antibodyfre
bbdr
rat
purchas
brm
inc
worcest
use
week
age
sentinel
anim
screen
studi
certifi
serolog
free
sendai
viru
pneumonia
viru
mice
sialodacryoaden
viru
rat
corona
viru
kilham
rat
viru
mous
polioviru
mycoplasma
pulmoni
lymphocyt
choriomening
viru
mous
adenoviru
hantaan
viru
encephalitozoon
cuniculi
anim
hous
viralantibodyfre
facil
provid
steril
food
water
ad
libitum
anim
maintain
accord
recommend
guid
care
use
laboratori
anim
institut
laboratori
anim
resourc
nation
research
council
nation
academi
scienc
guidelin
institut
anim
care
use
committe
iacuc
univers
massachusett
medic
school
flow
microfluorometri
surfac
antigen
fluorochromeor
biotinconjug
mab
direct
tcr
clone
clone
transferrin
receptor
clone
clone
chain
clone
chain
clone
clone
clone
clone
clone
clone
clone
clone
ifn
clone
purchas
bd
bioscienc
san
diego
ca
isotyp
control
mab
mous
mous
rat
hamster
ig
peor
cychrom
conjug
streptavidin
also
purchas
bd
bioscienc
antibodi
use
either
directli
conjug
fitc
pe
cychrom
use
biotin
conjug
develop
visual
peor
cychromestreptavidin
mous
antirat
mab
antirat
mhc
class
ii
antirat
mhc
class
isotyp
control
antidengu
viru
antibodi
produc
laboratori
purifi
use
protein
gplu
affin
chromatographi
column
calbiochem
san
diego
ca
purifi
neutral
rabbit
antibodi
rat
describ
ref
gener
provid
dr
nathan
karin
technion
haifa
israel
purifi
polyclon
rabbit
antibodi
irrelev
peptid
use
isotyp
control
purifi
polyclon
rabbit
antirat
ifn
torrey
pine
la
jolla
ca
antibodi
use
biotinconjug
antibodi
atoc
establish
bbdr
rat
thymi
describ
ref
thymic
fragment
cultur
day
humidifi
incub
atmospher
co
air
c
experi
syngen
bbdr
rat
serum
substitut
fetal
bovin
serum
expos
develop
bbdr
thymocyt
type
cytokin
atoc
cultur
ngml
mous
ngml
human
antirat
mab
cell
harvest
day
cultur
experi
incub
type
cytokin
secondari
cultur
cellsml
ngml
ngml
antirat
mab
addit
day
throughout
report
term
secondari
suspens
cultur
use
describ
secondari
cultur
thymocyt
type
cytokin
follow
primari
atoc
presenc
type
cytokin
primari
cultur
bbdr
cervic
mesenter
lymph
node
cell
suspens
cultur
type
cytokin
previous
describ
secondari
thymu
cultur
cell
recov
cultur
wash
three
time
hepe
bufferedrpmi
gibco
rockvil
md
viabl
cell
count
method
trypan
blue
exclus
use
hemocytomet
randomli
select
supernat
cultur
test
confirm
contain
eu
endotoxin
per
millilit
endosaf
charl
river
laboratori
charleston
sc
two
threecolor
flow
microfluorometri
analys
perform
describ
ref
briefli
viabl
cell
first
incub
biotinconjug
mab
min
ice
cell
wash
incub
addit
min
ice
fitcconjug
peconjug
cychromeconjug
antibodi
fluorochromeconjug
streptavidin
visual
biotinyl
mab
fitc
biotin
pe
cychrom
conjug
isotyp
control
immunoglobulin
use
analys
stain
detect
intracellular
ifn
perform
bbdr
atoc
cultur
c
variou
condit
day
cultur
atoc
day
follow
restimul
condit
secondari
cultur
addit
day
cell
set
cultur
harvest
count
recultur
day
supernat
cellsml
presenc
golgiplug
h
cell
react
antibodi
surfac
protein
wash
fix
permeabil
overnight
c
use
cytofix
cytoperm
reagent
bd
bioscienc
intracellular
cytokin
stain
perform
use
h
incub
ice
fitcantirat
ifn
fitcmous
isotyp
control
mab
cell
wash
fix
paraformaldehyd
analyz
use
facscan
instrument
becton
dickinson
sunnyval
ca
lymphoid
cell
identifi
electron
forward
side
lightscatt
characterist
surfac
stain
alon
event
analyz
combin
stain
intracellular
cytokin
surfac
marker
event
analyz
sampl
elisa
assay
rat
ifn
tnf
initi
perform
use
commerci
kit
accord
manufactur
direct
biosourc
intern
camarillo
ca
later
studi
use
commerci
avail
antibodi
bd
bioscienc
san
diego
ca
torrey
pine
la
jolla
ca
recombin
rat
cytokin
standard
recombin
mous
human
rat
ifn
rat
tnf
rat
purchas
r
system
minneapoli
mn
elisa
develop
use
detect
system
avidinperoxidas
opd
substrat
absorb
read
nm
use
elisa
plate
reader
molecular
devic
sunnyval
ca
elispot
assay
ifn
perform
previous
describ
western
blot
rat
use
recombin
rat
standard
purifi
goat
antirat
antibodi
secondari
biotinconjug
rabbit
antigoat
igg
antibodi
r
system
frozen
thaw
cell
pellet
indic
cultur
appli
lane
gel
develop
use
streptavidinhorseradish
peroxidas
vector
lab
ecl
western
blot
chemiluminesc
detect
reagent
amersham
pharmacia
biotech
inc
piscataway
nj
experi
antibodi
ad
type
cytokin
polar
cultur
follow
neutral
purifi
rabbit
antirat
antibodi
irrelev
purifi
rabbit
ig
ad
atoc
secondari
cultur
purifi
antimhc
class
antimhc
class
ii
mab
irrelev
isotyp
control
mab
equival
amount
protein
either
ad
day
secondari
cultur
antibodi
ad
atoc
cultur
antimhc
antibodi
would
interf
cell
select
ifn
product
measur
supernat
day
secondari
suspens
cultur
elisa
assay
analys
pharmacolog
inhibitor
adult
bbdr
rat
thymi
first
cultur
day
presenc
type
cytokin
previous
describ
atoc
harvest
cell
incub
concentr
cellsml
either
mab
coat
plate
presenc
mab
previous
describ
pharmacolog
inhibitor
ad
day
secondari
cultur
dissolv
steril
dmso
stock
prior
use
specif
compound
test
calcineurin
inhibitor
cyclosporin
ngml
map
kinas
inhibitor
fig
cytokin
product
phenotyp
cell
gener
atoc
panel
adult
bbdr
thymi
cultur
absenc
cytokin
uppermost
three
bar
presenc
type
cytokin
middl
three
bar
atoc
follow
suspens
cultur
presenc
type
cytokin
lowest
three
bar
describ
section
supernat
harvest
concentr
ifn
tnf
measur
elisa
data
point
repres
mean
sd
independ
trial
cytokin
concentr
shown
logarithm
scale
concentr
ifn
three
cultur
condit
statist
differ
cultur
condit
p
concentr
tnf
control
cultur
significantli
higher
two
cultur
condit
p
concentr
combin
atoc
suspens
cultur
significantli
higher
cultur
condit
p
pair
comparison
statist
signific
panel
b
c
bbdr
thymi
cultur
atoc
absenc
cytokin
gray
bar
atoc
presenc
type
cytokin
follow
suspens
cultur
type
cytokin
black
bar
cell
analyz
flow
microfluorometri
express
differenti
panel
b
activ
panel
c
marker
data
point
repres
mean
percentag
cell
indic
phenotyp
sd
three
five
independ
replic
percentag
obtain
use
isotyp
control
antibodi
uniformli
subtract
valu
shown
p
vs
control
untreat
cultur
tyrphostin
use
control
inhibitor
protein
tyrosin
kinas
dmso
vehicl
reagent
inhibitor
purchas
calbiochem
san
diego
ca
ifn
product
measur
supernat
day
indic
elisa
assay
parametr
data
present
arithmet
mean
standard
deviat
sd
group
three
mean
compar
oneway
analysi
varianc
least
signific
differ
procedur
posteriori
contrast
requir
data
log
transform
analysi
account
broad
varianc
pair
mean
compar
use
twotail
ttest
separ
varianc
estim
bonferroni
adjust
multipl
comparison
appli
necessari
bbdr
rat
atoc
use
determin
whether
exposur
differenti
cell
type
cytokin
intrathym
develop
would
alter
cytokin
product
activ
state
quantifi
cytokin
product
cell
gener
untreat
atoc
atoc
expos
type
cytokin
atoc
expos
type
cytokin
reexpos
condit
secondari
suspens
cultur
throughout
result
secondari
suspens
cultur
refer
cultur
perform
addit
type
cytokin
shown
fig
panel
cell
cultur
presenc
type
cytokin
atoc
produc
larg
amount
ifn
addit
secondari
suspens
cultur
contain
type
cytokin
increas
amount
ifn
produc
case
concentr
ifn
cultur
supernat
fold
greater
control
cultur
increas
amount
cytokin
secret
cultur
supernat
experiment
group
associ
progress
increas
number
cell
stain
posit
ifn
elispot
assay
tabl
cultur
perform
presenc
bovin
serum
could
argu
theori
increas
ifn
concentr
observ
experiment
cultur
due
activ
xenoreact
cell
address
possibl
perform
addit
set
experi
consist
atoc
plu
type
cytokin
follow
secondari
suspens
cultur
use
rat
serum
fetal
bovin
serum
observ
concentr
ifn
gener
cultur
statist
similar
pgml
use
rat
serum
pgml
use
bovin
serum
latter
valu
similar
shown
fig
condit
result
suggest
elev
ifn
secret
due
sole
xenogen
cell
reactiv
secret
tnf
increas
exposur
type
cytokin
fact
higher
control
atoc
either
cultur
condit
perform
presenc
type
cytokin
secret
similar
atoc
perform
without
addit
type
cytokin
significantli
increas
reexposur
type
cytokin
secondari
suspens
cultur
observ
increas
secondari
suspens
cultur
consist
publish
observ
ad
cultur
induc
cell
produc
could
measur
elisa
sinc
antibodi
ad
cultur
elispot
data
shown
tabl
indic
howev
number
cell
produc
small
cultur
condit
next
defin
phenotyp
thymocyt
cultur
three
condit
consist
previou
report
major
cell
recov
day
untreat
bbdr
rat
atoc
singleposit
cell
fig
panel
b
mani
cell
express
express
thymocyt
express
low
level
thymu
fig
panel
b
c
day
untreat
atoc
cell
express
activ
antigen
adult
bbdr
rat
thymocyt
cultur
absenc
cytokin
condit
presenc
type
cytokin
either
condit
without
condit
secondari
suspens
cultur
describ
section
number
ifn
secret
cell
quantifi
elispot
assay
individu
result
shown
three
independ
trial
fig
flow
cytometri
profil
cell
gener
atoc
adult
bbdr
thymi
cultur
presenc
type
cytokin
follow
secondari
cultur
presenc
type
cytokin
right
panel
primari
cultur
absenc
cytokin
secondari
suspens
cultur
left
panel
cell
harvest
react
antibodi
direct
indic
surfac
antigen
repres
flow
cytometri
profil
shown
complet
dataset
present
fig
isotyp
control
shown
inset
less
case
transferrin
receptor
fig
panel
c
addit
type
cytokin
bbdr
rat
atoc
effect
percentag
day
cell
express
activ
marker
data
shown
cell
harvest
secondari
suspens
cultur
howev
show
clear
evid
activ
major
cell
express
fig
panel
b
c
express
reduc
fig
panel
b
consist
activ
cell
larg
suggest
activ
fig
compar
control
atoc
cell
secondari
suspens
cultur
smaller
percentag
singl
posit
cell
increas
percentag
cell
fig
panel
b
observ
howev
cell
fact
cell
tcr
hi
phenotyp
data
shown
activ
cell
rat
express
chain
data
suggest
doubl
posit
cell
actual
activ
singl
posit
cell
secondari
suspens
cultur
also
associ
increas
cell
surfac
densiti
chain
fig
synerg
induc
antigenindepend
activ
cell
also
amplifi
tcrdriven
type
polar
respons
analyz
role
activ
atocderiv
cell
western
blot
analysi
perform
lysat
cell
obtain
atoc
detect
cleav
activ
form
inact
precursor
form
rat
cell
recov
atoc
cultur
type
cytokin
secondari
suspens
cultur
fig
amount
activ
form
decreas
time
amount
precursor
increas
observ
probabl
due
fact
activ
form
secret
medium
test
analysi
presenc
suggest
may
involv
antigenindepend
activ
cell
induct
ifn
secret
system
altern
possibl
cell
activ
mediat
signal
tcr
follow
interact
mhcselfpeptid
use
pharmacolog
inhibitor
discrimin
possibl
cell
atoc
incub
type
cytokin
recov
cultur
suspens
presenc
either
type
cytokin
immobil
mab
posit
control
tcrmediat
signal
type
secondari
cultur
treat
either
csa
inhibit
tcrmediat
signal
affect
cell
activ
mediat
plu
mapkinas
inhibitor
inhibit
tcrmediat
cell
activ
tyrphostin
reportedli
inhibit
either
pathway
dmso
vehicl
compound
concentr
ifn
supernat
day
secondari
cultur
quantifi
elisa
comparison
dmso
control
cultur
cyclosporin
inhibit
ifn
product
induc
time
point
fig
panel
confirm
publish
data
expect
neither
tyrphostin
effect
mab
induc
ifn
product
contrast
fig
panel
b
cell
activ
induc
type
cytokin
inhibit
csa
time
point
also
inhibit
tyrphostin
much
lesser
extent
effect
tyrphostin
may
repres
recent
describ
abil
inhibit
tyrosin
kinas
activ
associ
signal
inhibitor
data
suggest
tcrmediat
activ
cytokin
signal
pathway
involv
activ
cell
atoc
expos
type
cytokin
investig
tcrmediat
activ
ad
antibodi
rat
mhc
class
mhc
class
ii
secondari
suspens
cultur
perform
type
cytokin
antimhc
mab
ad
time
secondari
suspens
cultur
order
permit
intrathym
select
occur
primari
atoc
also
test
antibodi
rat
case
ad
antibodi
atoc
suspens
cultur
comparison
control
cultur
perform
use
isotyp
control
antibodi
ifn
product
reduc
antimhc
class
antimhc
class
ii
antibodi
alon
combin
two
antibodi
neutral
antibodi
fig
panel
c
result
consist
inhibitor
data
suggest
tcrmediat
signal
involv
activ
atocderiv
cell
incub
type
cytokin
next
determin
rel
contribut
product
ifn
rat
atoc
standard
condit
use
polar
rat
cell
ngml
ngml
atoc
assign
valu
pgml
ifn
day
atoc
three
four
independ
trial
fig
panel
show
level
ifn
produc
differ
treatment
condit
percentag
ifn
product
standard
condit
combin
effect
ifn
level
cultur
receiv
ngml
plu
ngml
averag
level
observ
cultur
also
includ
standard
condit
howev
alon
suffici
polar
cell
evalu
dose
could
effect
polar
thymocyt
type
cytokin
profil
dose
titrat
studi
fivefold
lower
concentr
use
togeth
fig
panel
show
even
low
concentr
ifn
product
still
averag
level
observ
standard
condit
ngml
cellular
origin
ifn
atoc
determin
surfac
label
tcr
follow
intracellular
stain
ifn
tabl
show
distribut
ifn
cell
within
tcr
tcr
compart
within
preselect
popul
posit
select
tabl
fig
panel
atoc
harvest
recultur
treatment
condit
addit
day
secondari
cultur
type
cytokin
polar
measur
frequenc
ifn
cell
determin
intracellular
stain
mous
isotyp
control
antibodi
use
determin
background
stain
subtract
percent
valu
shown
result
shown
mean
frequenc
ifn
cell
sd
three
four
independ
determin
panel
b
frequenc
ifn
cell
tcr
tcr
popul
day
secondari
cultur
ifn
level
significantli
differ
standard
condit
shown
uppermost
bar
p
panel
c
frequenc
ifn
cell
popul
day
secondari
cultur
statist
signific
differ
observ
frequenc
ifn
cell
cell
compart
data
shown
omiss
significantli
decreas
frequenc
ifn
cell
treatment
c
rel
standard
condit
appear
necessari
optim
induct
ifn
day
atoc
treatment
f
vs
b
c
frequenc
ifn
cell
similar
group
receiv
ngml
treatment
b
g
h
cellular
origin
ifn
also
determin
secondari
cultur
treatment
condit
time
day
initi
atoc
cultur
virtual
cell
posit
select
phenotyp
upregul
tcr
tcr
cell
cell
produc
ifn
fig
panel
b
equal
divid
tcr
subset
treatment
condit
fig
panel
c
observ
atoc
cultur
synerg
induct
ifn
cell
dose
induc
compar
frequenc
ifn
cell
secondari
cultur
differ
frequenc
ifn
cell
cultur
receiv
effect
alon
without
cytokin
could
determin
cell
treatment
group
surviv
secondari
cultur
polar
adult
rat
thymocyt
cultur
knowledg
previous
report
sought
compar
respons
cultur
convent
cultur
peripher
lymph
node
cell
bbdr
rat
lymph
node
cell
suspens
cultur
either
type
cytokin
concentr
use
cultur
atocderiv
cell
presenc
mitogen
con
day
correspond
end
atoc
lymph
node
cell
cultur
type
cytokin
secret
ifn
cell
con
stimul
cultur
fig
panel
p
concentr
ifn
supernat
lymph
node
cultur
perform
type
cytokin
found
atoc
supernat
fig
panel
data
permit
determin
product
ifn
per
cell
basi
lymph
node
cell
cultur
type
cytokin
secret
wtwofold
tnf
cell
con
aactiv
cultur
concentr
low
condit
also
compar
cell
surfac
phenotyp
lymph
node
cell
cultur
presenc
type
cytokin
freshli
isol
lymph
node
cell
fig
panel
b
c
littl
evid
activ
freshli
isol
lymph
node
cell
cultur
lymph
node
cell
type
cytokin
small
popul
cell
express
chain
activ
marker
detect
attempt
extend
comparison
polar
lymph
node
cell
thymocyt
harvest
lymph
node
cell
cultur
perform
secondari
cultur
done
thymocyt
found
howev
secondari
cultur
lymph
node
cell
type
cytokin
led
death
cell
day
cultur
presum
due
activ
induc
cell
death
cytokin
polar
peripher
cell
tcr
engag
import
mechan
regul
type
immun
respons
gener
foreign
antigen
autoantigen
present
atoc
establish
day
indic
treatment
day
cultur
harvest
stain
surfac
marker
intracellular
ifn
describ
section
result
shown
mean
sd
three
four
independ
trial
ratio
cell
singl
posit
cell
experi
approxim
treatment
condit
fig
cytokin
product
cellular
phenotyp
bbdr
lymph
node
cell
panel
bbdr
lymph
node
cell
cultur
presenc
con
type
cytokin
day
concentr
ifn
tnf
cultur
supernat
determin
elisa
data
point
repres
mean
sd
four
independ
trial
statist
signific
differ
two
group
panel
b
bbdr
lymph
node
cell
cultur
type
cytokin
day
black
bar
sampl
freshli
isol
bbdr
rat
lymph
node
cell
gray
bar
harvest
analyz
flow
cytometri
express
differenti
panel
b
activ
panel
c
antigen
data
point
repres
mean
percentag
cell
sd
lymphocyt
fraction
express
indic
antigen
three
five
independ
experi
percentag
obtain
use
isotyp
control
antibodi
uniformli
subtract
valu
shown
p
vs
freshli
isol
cell
studi
demonstr
exposur
thymocyt
type
cytokin
intrathym
select
also
modul
cell
activ
cytokin
product
cell
deriv
type
cytokinecondit
rat
atoc
spontan
produc
larg
amount
ifn
reexposur
cell
type
cytokin
induc
even
product
ifn
associ
cell
activ
event
occur
absenc
exogen
foreign
antigen
ifn
dataset
suggest
suscept
adult
thymocyt
polar
qualit
similar
peripher
lymph
node
cell
expos
type
cytokin
absenc
antigen
polar
develop
thymocyt
type
cytokin
knowledg
report
previous
data
clearli
document
secret
copiou
amount
ifn
cell
activ
follow
exposur
atoc
type
cytokin
importantli
data
suggest
intrathym
polar
could
import
process
vivo
well
vitro
note
princip
agent
polar
use
studi
synthes
thymu
circul
high
level
exposur
certain
pathogen
follow
administr
cpg
dna
nonleth
dose
toxoplasma
gondii
toxoplasma
cruzi
mcmv
cpg
dna
given
mice
result
circul
level
rang
ngml
persist
serum
h
day
ex
vivo
product
cell
mice
given
cpg
dna
gondii
mycoplasma
bovi
rang
ngml
h
cultur
spleen
lymph
node
cell
cultur
apc
cultur
human
pbl
monocyt
seven
differ
speci
gram
posit
bacteria
heliobact
pylori
induc
product
ngml
h
cultur
addit
viru
infect
human
mice
increas
sensit
concurr
subsequ
bacteri
challeng
mechan
involv
elev
serum
level
proinflammatori
cytokin
includ
circul
level
follow
exposur
certain
pathogen
therefor
compar
abl
polar
thymocyt
atoc
detect
intrathym
polar
vivo
would
difficult
undertak
due
complex
kinet
associ
continu
influx
bone
marrow
immigr
intrathym
death
immigr
efflux
matur
cell
key
discoveri
use
atoc
thymocyt
surviv
poorli
cell
suspens
cultur
irrespect
whether
cell
cultur
presenc
absenc
type
cytokin
bjw
unpublish
observ
contrast
rat
atoc
allow
normal
thymocyt
develop
select
occur
vitro
overcom
problem
vivo
studi
allow
analysi
cell
develop
absenc
seed
thymu
thymocyt
progenitor
absenc
emigr
thymu
rat
atoc
recapitul
faith
normal
rat
intrathym
cell
development
kinet
phenotyp
gener
singl
posit
cell
upregul
tcr
characterist
peripher
cell
observ
rat
atoc
gener
singleposit
cell
basi
hypothesi
thymocyt
might
respond
polar
effect
type
cytokin
result
tcr
engag
select
also
hypothes
exposur
atoc
type
cytokin
might
lead
cell
activ
antigenindepend
mechan
describ
mous
human
peripher
cell
cultur
present
data
confirm
hypothes
suggest
antigendepend
antigenindepend
mechan
contribut
intrathym
cell
polar
respect
antigendepend
mechan
document
antimhc
mab
block
tcrmhcligand
cognat
interact
reduc
cell
polar
particip
tcr
engag
confirm
use
cyclosporin
block
cell
activ
mediat
tcr
signal
interpret
data
suggest
tcrmhcligand
interact
play
import
role
activ
cell
cultur
type
cytokin
recogn
xenogen
reactiv
bovin
serum
could
altern
explan
result
control
cultur
perform
rat
serum
larg
exclud
possibl
respect
antigenindepend
mechan
intrathym
polar
document
neutral
antibodi
mapkinas
inhibitor
also
reduc
cell
polar
observ
consist
view
cytokinedriven
antigenindepend
pathway
particip
intrathym
polar
recogn
howev
synerg
activ
cell
presenc
absenc
antigen
impli
could
particip
antigendepend
antigenindepend
polar
process
demonstr
ifn
produc
atoc
secondari
cultur
origin
cell
atoc
polar
occur
preselect
postselect
singl
posit
thymocyt
tabl
polar
doubl
posit
thymocyt
might
predict
observ
cell
show
heighten
sensit
stimul
low
affin
peptidemhc
complex
compar
matur
cell
even
though
surfac
tcr
level
lower
secondari
exposur
type
cytokin
substanti
increas
percent
ifn
cell
exposur
thymocyt
type
cytokin
environ
clearli
prime
cell
heighten
respons
secondari
exposur
condit
combin
optim
type
cytokin
polar
atoc
secondari
cultur
tabl
fig
suffici
bia
cell
type
cytokin
respons
shown
facilit
ifn
product
atoc
secondari
cultur
unabl
detect
day
atoc
elisa
cultur
receiv
plu
pgml
four
determin
possibl
could
produc
earlier
atoc
andor
util
day
base
observ
exposur
develop
thymocyt
polar
condit
gener
activ
cell
specul
exposur
thymocyt
vivo
analog
condit
may
repres
mechan
underli
gener
surviv
selfreact
cell
genet
predispos
individu
polar
condit
present
thymu
selfreact
might
result
interfer
neg
select
high
affin
selfreact
cell
promot
posit
select
altern
selfantigen
might
crosspres
cell
result
cytokin
induc
matur
apc
mechan
describ
peripher
cell
mani
selfantigen
express
thymic
stromal
cell
correl
studi
suggest
intrathym
selfantigen
express
may
play
import
role
cell
toler
selfantigen
normal
express
level
low
induc
posit
select
might
context
proinflammatori
environ
upregul
apc
function
lower
threshold
cell
activ
role
type
cytokin
alter
select
intrathym
develop
unknown
perturb
intrathym
select
experiment
system
shown
lead
gener
autoreact
cell
environment
perturb
gener
infect
particular
implic
pathogenesi
sever
autoimmun
diseas
polar
condit
within
thymu
result
high
circul
level
gener
infect
could
repres
mechan
link
genet
suscept
autoreact
environment
trigger
autoimmun
diseas
hypothesi
intrathym
exposur
type
polar
condit
could
lead
loss
selftoler
impli
activ
cell
deriv
bbdr
rat
atoc
expos
type
cytokin
selfreact
preliminari
studi
use
adopt
transfer
method
suggest
fact
case
bjw
unpublish
observ
summari
document
develop
thymocyt
expos
type
cytokin
vitro
becom
polar
toward
type
cytokin
profil
combin
antigendepend
cytokinedriven
mechan
specul
thymocyt
vivo
could
expos
type
cytokin
environ
result
produc
endogen
respons
infect
rel
import
intrathym
polar
normal
physiolog
respons
mechan
pathophysiolog
process
lead
autoimmun
remain
studi
laboratori
